Follow-up study of 11 patients with potentially reversible tardive dyskinesia
Abstract
The authors followed the course of 11 patients with potentially reversible tardive dyskinesia while they were taking minimum effective neuroleptic doses. After 10 years, the symptoms of tardive dyskinesia had disappeared in eight patients, were minimal or questionable in one, and had become persistent in two.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
